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a b s t r a c t
Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a crucial role in cellular defence against oxidative
stress by inducing the expression of multiple anti-oxidant genes. However, where high levels of oxidative
stress are observed, such as chronic obstructive pulmonary disease (COPD), Nrf2 activity is reduced,
although the molecular mechanism for this defect is uncertain. Here, we show that down-regulation of
histone deacetylase (HDAC) 2 causes Nrf2 instability, resulting in reduced anti-oxidant gene expression
and increase sensitivity to oxidative stress. Although Nrf2 protein was clearly stabilized after hydrogen
peroxide (H2O2) stimulation in a bronchial epithelial cell line (BEAS2B), Nrf2 stability was decreased
and Nrf2 acetylation increased in the presence of an HDAC inhibitor, trichostatin A (TSA). TSA also
reduced Nrf2-regulated heme-oxygenase-1 (HO-1) expression in these cells, and this was conﬁrmed in
acute cigarette-smoke exposed mice in vivo. HDAC2 knock-down by RNA interference resulted in reduced
H2O2-induced Nrf2 protein stability and activity in BEAS2B cells, whereas HDAC1 knockdown had no
effect. Furthermore, monocyte-derived macrophages obtained from healthy volunteers (non-smokers
and smokers) and COPD patients showed a signiﬁcant correlation between HDAC2 expression and Nrf2
expression (r = 0.92, p < 0.0001). Thus, reduced HDAC2 activity in COPD may account for increased
Nrf2 acetylation, reduced Nrf2 stability and impaired anti oxidant defences.
 2011 Elsevier Inc.
1. Introduction
Nrf2 is a redox-sensitive transcription factor that regulates the
expression of phase II anti oxidant genes and confers cytoprotection
against oxidative stress [1,2]. In unstressed cells Nrf2 is sequestered
by its inhibitor, Keap1, that promotes rapid proteasome-mediated
degradation via a Cul3 based E3 ubiquitin ligase complex [3]. How-
ever, in response to oxidative stress Nrf2 is stabilized by dissociat-
ing from Keap1, and binds to cis-elements called ‘‘antioxidant
response elements’’ (ARE) as a heterodimer with other members
of the basic leucine zipper protein family, such as Maf or Jun [4].
Nrf2 is localized mainly in the nucleus of airway epithelial cells
and alveolar macrophages in lung and maintains anti-oxidant
capacity to environmental or endogenous oxidative stress insults
[5]. Persistent overload of reactive oxygen species (ROS) is reported
to result in chronic inﬂammation in the lungs of patients with
chronic obstructive pulmonary disease (COPD) [6]. In fact, Nrf2-
deﬁcient mice are highly sensitive to oxidative stress and develop
severe emphysema to cigarette smoke [7,8]. Recently, whole lung
tissue and alveolar macrophages from emphysema patients were
reported to show decreased Nrf2 protein expression and activity
and anti-oxidant genes due to an increase in the negative regulators
Keap1 and Bach1 [9]. Another study on lung homogenates from pa-
tients with COPD found that defective Nrf2 expression was due to
decreased expression of its positive regulator DJ-1 [10]. Peripheral
lung and alveolar macrophages of COPD patients are also defective
in histone deacetylase 2 (HDAC2), resulting in corticosteroid insen-
sitive inﬂammation via hyper-acetylation of histones and glucocor-
ticoid receptors [11,12]. Nrf2 has been recently found to be
regulated by acetylation [13]. We therefore hypothesized that
HDAC2 may control Nrf2 activity via deacetylation and that a de-
crease in HDAC2 may cause impaired function of Nrf2 leading to
down-regulation of anti-oxidant responsive genes, such as HO-1.
2. Materials and methods
2.1. Cell culture, MDMs and stimulation
BEAS2B cells (human airway epithelial), (ATCC Teddington, UK)
were cultured in keratinocyte media (Invitrogen, Paisley, UK)
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bovine pituitary extracts (BPE). For mRNA stability experiments,
BEAS2B cells were stimulated with actinomycin-D (Sigma, Poole,
UK) (5 lM) and TSA (Sigma) (10 ng/ml) at the same time and incu-
bated from 0 to 4 h. For protein stability experiments, BEAS2B cells
were stimulated with cycloheximide (Sigma) (0.5 lg/ml) from 0 to
70 min in the presence of 30 min pre-incubation with TSA (50 ng/
ml) and/or stimulation with H2O2 (50 lM) at the same time as
cycloheximide.
Monocytes were isolated from peripheral blood mononuclear
cells obtained from ﬁve healthy, three normal smoker volunteers
and ﬁve COPD volunteers and differentiated into monocyte-
derived macrophages [14]. Ethics approval was obtained from
the Ethics Committee of the Royal Brompton & Hareﬁeld Hospitals
National Health Service Trust, and all subjects gave written
informed consent.2.2. Nuclear and whole cell extraction
Nuclear extractions were performed using the Active Motif Nu-
clear Extraction kit (Rixensard, Belgium) following manufacturer’s
instructions. Whole cell extracts were prepared using 0.5% (v/v)
NP40 RIPA buffer as previously described [14].2.3. Nrf2 activity assay
Cells were stimulated with H2O2 (75 lM) for different time
points (0–24 h), with pre-treatment of TSA (0.1–1000 ng/ml) or
MG132 (5 lg/ml) and nuclear extracts were used for the determi-
nation of Nrf2 binding activity to immobilized anti-oxidant
response elements (ARE) using a TransAMTM Nrf2 kit (Active
Motif).Fig. 1. Hydrogen peroxide (H2O2) increases Nrf2 protein and activity in BEAS2B cells. (A
Western blotting and normalized to the oxidant insensitive protein lamin C (n = 3). (B) Th
Western blot analysis of BEAS2B cell nuclear extracts stimulated with H2O2 (1–100 lM)
HO-1 mRNA expression was normalized to GNB2L1 and analysed using qRT-PCR; NT: n2.4. siRNA studies
BEAS2B cells were transfected with HDAC2 (10 nM) (Qiagen,
Crawley, UK), HDAC1 (5 nM) (Dharmacon, Epsom, UK) or random
oligonucleotide control (RO, 10 nM) siRNA (Qiagen) for 48 h using
HiPerfect transfection reagent (Qiagen, Crawley, UK) following the
manufacturer’s instructions.
2.5. Immunoprecipitation
Whole cell extracts from BEAS2B cells that were stimulated
with MG132 (5 lg/ml, 2 h) and TSA (10 ng/ml, 1–2 h) were
pre-cleared using rabbit polyclonal IgG and Protein A/G (Santa Cruz
Biotechnology, Heildelberg, Germany) for 30 min. Supernatants
were then incubated overnight with rabbit anti-Nrf2 (Santa Cruz)
antibody at 4 C and immunoprecipitation was performed as
previously described [15].
2.6. Western blot
Proteins from whole-cell and nuclear extracts were separated
by 10% SDS–PAGE (Invitrogen, Carlsbad, CA). Primary antibodies
against Nrf2 (Rabbit, Santa Cruz and Mouse, R&D Systems),
pan-acetylated lysine (Ac-K) (Bioscience, Cambridge, UK), b-actin
(Abcam, Cambridge, UK), TBP (Abcam), HDAC1 (Sigma), HDAC2
(Sigma), Keap1, DJ-1 and Lamin A/C (Santa Cruz) were used to
detect protein expression.
2.7. Animals and treatments
C57BL/6 mice (male, 8 week) were exposed to cigarette smoke
for 5 h using a TE-10 smoke machine (Teague Enterprises, Davis,) Cells were treated H2O2 (75 lM) for 0.5–24 h and nuclear Nrf2 was measured by
e same nuclear extracts were used for measurement of Nrf2 DNA binding (n = 3). (C)
for 30 min (n = 3). (D) BEAS2B cells were stimulated with H2O2 (75 lM) for 8 h and
on-treatment. Values represent means ± SEM, ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.005.
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concentration of 250 mg/m3 as previously described [16]. One hour
prior to cigarette smoke, mice were treated with vehicle and or TSA
at a dose of 100 ug/ml in 50 ll of PBS intranasally. Immediately
after cigarette smoke exposure, lungs were isolated and stored in
fresh RNA later (Qiagen).2.8. Real-time quantitative PCR
Total cellular RNA was extracted and cDNA was prepared as
previously reported [11]. Real-time quantitative PCR (qRT-PCR)
analysis of Nrf2 and GAPDH was performed using Taqman primer
and probe set from Applied Biosystems (Warrington, UK), and HO-
1 and GNB2L1 using Taqman primers and probe sets from Qiagen
in the Corbett Rotor Gene 6000. For animal studies, qRT-PCR anal-
yses was carried using Taqman primer probe set and reactions
were analyzed using the ABI 7000 Taqman system as previously
described [16].Fig. 2. HDAC2 inhibition reduces Nrf2 protein stability. (A) BEAS2B cells were treated w
Nrf2 was measured by Western blotting. (B) Nrf2 DNA binding activity was measured in
to 30 min exposure to H2O2 (75 lM; n = 3; ⁄p < 0.05, ⁄⁄p < 0.01 vs. H2O2). (C) Cells were sti
lamin A/C expression by Western blotting. NT: non-treatment; n = 3. (D) Cells were stimu
treatment with TSA (50 ng/ml). Cells were also stimulated with CXM in the presence of
were analyzed by Western blot for Nrf2 and TBP as nuclear control. NT: non-treatment; n
Cells were treated with TSA (10 ng/ml) for 1.5 h prior to 8 h with H2O2 (75 lM). HO-1 e
between NT and H2O2, #p < 0.05 between TSA and H2O2). (F) Mice were treated with intran
measured against b-actin using QRT-PCR, (#p < 0.05 vs. Air/Veh, ⁄p < 0.05 vs. CS/Veh, (n =
kd) or a random oligonucleotide (RO) for 48 h and stimulated with H2O2 (50 lM) for 30 m
cell extracts. Values represent means ± SEM, n = 4, ⁄p < 0.05.2.9. Statistical analysis
Data are expressed as median ± SEM. Results were analyzed
using t-test for hydrogen peroxide stimulation and one-way Anova
for repeated measures with Dunnett post-test to determine the
effect of various TSA concentrations. For MDMs, non-parametric
Wilcoxon matched pairs was used to measure the effect of H2O2
or TSA. The Graph Pad Prism Software (Prism, San Diego, CA) was
used for statistical calculations. p < 0.05 was considered statisti-
cally signiﬁcant.3. Results
3.1. Hydrogen peroxide increases Nrf2 protein levels and activity in
BEAS2B cells
H2O2 (75 lM) increased Nrf2 protein levels as measured by
Western blotting (Fig. 1A). Nuclear Nrf2 protein expression peakedith TSA (0.1–10 ng/ml) for 1.5 h prior 30 min exposure to H2O2 (75 lM) and nuclear
nuclear extracts stimulated with trichostatin A (TSA 0.1–1000 ng/ml) for 1.5 h prior
mulated with TSA (10 ng/ml) for 180 min and nuclear extracts analyzed for Nrf2 and
lated with cycloheximide (CXM 0.5 lg/ml) in the presence or absence of 30 min pre-
H2O2 (50 lM) with or without pre-treatment with TSA for 30 min. Nuclear extracts
= 3. NT vs. TSA and H2O2 vs. H2O2 + TSA for each time point (⁄p < 0.05, ⁄⁄p < 0.01). (E)
xpression was measured by QRT-PCR with GNB2L1 used as control (n = 3; ⁄p < 0.05
asal TSA or vehicle (Veh) for 1 h prior to 5 h to cigarette smoke (CS) or air. HO-1 was
5/group)). (G) Cells were transfected with HDAC2 siRNA (H2 kd), HDAC1 siRNA (H1
in. Nrf2, HDAC2, HDAC1 and Lamin A/C were measured by Western blot from whole
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decreased to basal levels after 24 h. The same nuclear extracts
were used to measure the binding ability of nuclear Nrf2 to ARE
and showed the same pattern of early peak binding at 30 min
(2.1 ± 0.2-fold; p < 0.01) (Fig. 1B). When cells were treated with
different concentrations of H2O2 (1–100 lM) for 30 min, Nrf2
expression was maximal between 50 and 75 lM of H2O2. Expres-
sion of the oxidative stress responsive gene, HO-1, which confers
cytoprotection against oxidative stress [17], was increased
(3.4 ± 0.1-fold; p < 0.005) 8 h after H2O2 treatment (Fig. 1D).3.2. HDAC inhibition reduces Nrf2 stability and impairs Nrf2 activation
by oxidative stress
BEAS2B cells were treated with non-selective Class I and II
HDAC inhibitor, TSA, to mimic the conditions seen in COPD
[11]. As shown in Fig. 2B, TSA concentration-dependently inhib-
ited Nrf2 activity in nuclear extracts, with maximum inhibition
of 53% at 100 ng/ml. Nrf2 was not further inhibited at higher con-
centration of TSA (Nrf2 induction; 1.7 ± 0.1-fold a 100 ng/ml,
1.9 ± 0.2-fold at 10 ng/ml vs. H2O2: 2.5 ± 0.1-fold; p < 0.01). Thus,
the inhibitory effect of TSA on the nuclear Nrf2 levels was signif-
icant but incomplete. In addition, when analyzing the same nu-
clear extracts by Western blot, Nrf2 protein levels were reduced
at 10 ng/ml of TSA (Fig. 2A). The inhibition by TSA also happened
in baseline Nrf2 and was detected 15 min after treatment, peak-
ing at 60 min and lasting for 180 min (Fig. 2C). Although some re-
ports indicate that Nrf2 is located in the cytoplasm [18,19], our
experiments show that Nrf2 is detectable only within nuclei, be-
fore and after H2O2 treatment (Supplementary Fig. S1) and that
TSA (10 ng/ml) prevents an increase of Nrf2 in the nucleiFig. 3. HDAC2 and Nrf2 expression correlation in monocyte-derived macrophages. (A) MD
were stimulated with H2O2 (50 lM) for 30 min prior to whole-cell extraction and Weste
whole cell extracts from unstimulated BEAS2B cells was used as positive control (Ct). (B
COPD patients were stimulated with H2O2 (50 lM) for 30 min and expression of Nrf2 wa
samples (n = 13). (D) MDMs from four healthy volunteers were stimulated with TSA (50 n
was normalized against b-actin. Values represent means ± SEM. NT (Non-treatment). ⁄p(Fig. 2B, Supplementary Fig. S1). Nrf2 protein half-life was mea-
sured by incubating cells in the presence of translational inhibitor
cycloheximide (Fig. 2D). At baseline, Nrf2 was quickly degraded
by the proteasome with a half-life of 6 min (t½ = 6 min) similar
to other studies [18,20]. Hydrogen peroxide increased the stabil-
ity of the protein (t½ = 33 min) and pre-incubation of TSA de-
creased baseline Nrf2 stability (t½ = 1.4 min) as well as H2O2-
stimulated Nrf2 stability (t½ = 13.8 min) (Fig. 2D). The reduction
of Nrf2 protein levels after TSA was not caused by decreased
Nrf2 transcription or reduced mRNA half-life as shown by an
experiment using actinomycin D (Supplementary Fig. S2A and
B). Additionally, we tested the inhibition of Class III HDACs (sirtu-
ins) using sirtinol, a non-speciﬁc sirtuin inhibitor and measured
the effect of H2O2 on Nrf2 protein levels. Results show that in-
crease in Nrf2 stability is not controlled by Sirtuins (Supplemen-
tary Fig. S2C). TSA also signiﬁcantly inhibited H2O2-stimulated
HO-1 expression (TSA: 1.9 ± 0.3-fold vs. H2O2: 3.4 ± 0.5-fold;
p < 0.05, Fig. 2E).3.3. HDAC inhibition impairs cigarette smoke-induced anti-oxidant
response in mice in vivo
We performed an in vivo experiment to conﬁrm the effects of
HDAC inhibition on HO-1 expression observed in vitro. Mice were
exposed to cigarette smoke for 5 h, and pulmonary HO-1 mRNA
expression determined. As shown in Fig. 2F, cigarette smoke signif-
icantly increased HO-1 mRNA (CS/Veh; 3.74 ± 0.42 RFC vs. Air/Veh:
2.25 ± 0.44 RFC, p < 0.05). When TSA was given intranasally prior to
CS exposure (100 lg/ml, 50 ll/mouse), HO-1 expression was sig-
niﬁcantly inhibited (CS/Veh; 3.74 ± 0.42 RFC vs. CS/TSA:
2.25 ± 0.41 RFC, p < 0.05) (Fig. 2F).Ms from a healthy volunteer (HV), a smoking volunteer (SV) and two COPD patients
rn blotting. The expression of Nrf2, DJ-1, HDAC2, Keap1 and b-actin are shown. The
) MDMs from ﬁve healthy volunteers (HV), three smoking volunteers (SV) and ﬁve
s normalized against b-actin. (C) Nrf2 and HDAC2 expression were correlated in all
g/ml) for 1.5 h prior exposure to H2O2 (50 lM) for 30 min and the expression of Nrf2
< 0.01 for NT vs. H2O2 and #p < 0.01 for H2O2 vs. TSA (H2O2).
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activation
TSA strongly inhibits class I and class II HDAC activities but only
HDAC2 is selectively down-regulated in the lung and alveolar mac-
rophages from patients with COPD [11]. Selective inhibition of
HDAC2 in BEAS2Bs was performed using short interference RNA
with HDAC1 knock-down as a control. Transfection of siRNA tar-
geting HDAC2 induced 45% reduction of protein level (Fig. 2G).
H2O2 stimulation resulted in an increase in Nrf2 stability
(2.4 ± 0.2-fold) in random oligonucleotide (RO) transfection
controls whereas HDAC2 KD showed a signiﬁcant reduction of both
basal levels of Nrf2 (0.5 ± 0.0-fold; p < 0.05) and H2O2 stimulated
Nrf2 (1.5 ± 0.3-fold; p < 0.05) compared with RO controls
(Fig. 2G). By contrast, RNA interference of HDAC1 achieved 67%
reduction of protein level, but HDAC1 KD did not alter basal or
H2O2-stimulated Nrf2 stability (Fig. 2G).3.5. HDAC2 protein correlates with Nrf2 protein expression in MDMs
Monocytes were collected from blood obtained from healthy
subjects, smoking volunteers and COPD patients (Supplementary
Table 1) and differentiated into MDMs. Cells were stimulated with
H2O2 and Nrf2 protein was determined by Western blotting.
As shown in Fig. 3A and B, basal Nrf2 expression was decreased
in COPD compared to healthy volunteers although the difference
was not signiﬁcant (Fig. 3B). H2O2 increased Nrf2 protein levels
in all subject and no signiﬁcant differences in Nrf2 activation were
observed between patients. However, a signiﬁcant correlation wasFig. 4. Nrf2 is acetylated with HDAC inhibition. (A) BEAS2B cells were treated with the p
Nrf2 and lamin C (control) were detected in nuclear extracts by Western blotting. (B
(⁄⁄p < 0.01 and ⁄⁄⁄⁄p < 0.0001 vs. NT [non-treatment]). (C) BEAS2B cells were stimulated
immunoprecipitated and acetylated-lysine (Ac-K) and HDAC2 were detected with the re
IgG: negative control for immunoprecipitation where no cellular lysates where used. The
density of acetylated Nrf2 was determined and normalized to total Nrf2 expression (n = 3
from whole cell extracts under the same conditions used in (C).found between unstimulated Nrf2 expression and HDAC2 (r = 0.92,
p < 0.0001, Fig. 3C). Additionally, TSA impaired Nrf2 increase in
protein levels induced by H2O2 in MDMs from healthy volunteers
(Fig. 3D), conﬁrming results described in BEAS2B cells.
The expression levels of DJ-1 and Keap1 have previously been
implicated in Nrf2 stability [9,10,21,22] but no differences in
expression of DJ-1 or Keap1 were observed in COPD patients com-
pared with healthy subjects (Fig. 3A). No correlation was also
found between Nrf2 and DJ-1 (r = 0.45, p = 0.12) but the correla-
tion with Keap1 almost reached signiﬁcance (r = 0.54, p = 0.055),
which has been previously observed in cancer cells [22].3.6. HDAC2 is associated with Nrf2 and HDAC reduction causes
acetylation of Nrf2
In order to measure acetylation levels of Nrf2, high amount of
the protein were obtained by treating BEAS2B cells with MG132,
a proteasome inhibitor, preventing degradation of Nrf2. As shown
in Fig. 4A, although H2O2 signiﬁcantly stabilized Nrf2 protein in
nuclei, MG132 further stabilized Nrf2 by approximately 4-fold.
This suggests that H2O2 (75 lM) stabilized approximately 50% of
total translated Nrf2. Nrf2 expression correlated with its activity
(Fig. 4B). Nrf2 acetylation was measured after TSA treatment as
shown in Fig. 4C. HDAC2 protein was detected in Nrf2 immunopre-
cipitates, suggesting that Nrf2 associates with HDAC2. This
association was not altered in the presence of TSA (10 ng/ml) at
1 or 2 h stimulation prior whole-cell extraction. Nrf2 was also
lysine-acetylated at baseline, and acetylation was increased in
the presence of TSA at 1 and 2 h, reaching signiﬁcance at 2 hroteasome inhibitor MG132 (5 lg/ml) for 1.5 h or with H2O2 (75 lM) for 30 min and
) Nrf2 activity was determined in the same extracts using a TransAM kit, (n = 4),
with MG132 (5 lg/ml) for 2 h, with/without TSA (10 ng/ml for 1–2 h). Nrf2 was
levant-antibody. IP: immunoprecipitation, IB: immunoblot, WC: whole cell extracts.
arrow (?) indicates the correct Nrf2 protein size in the whole cell extracts. (D) Band
), ⁄p < 0.05 vs. NT (non-treatment). Keap1 (E) and DJ-1 (F) were immunoprecipitaed
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Keap1 and DJ-1 in the presence of MG132 and/or TSA were not
found to be acetylated (Fig. 4E and F).4. Discussion
We have shown that in a COPD model, in which Class I and II
HDACs are inhibited, Nrf2 protein is further acetylated and its
stability is decreased along with its anti-oxidant potential which
might contribute to COPD pathogenesis. We have also identiﬁed
HDAC2 as one of the deacetylases likely to be responsible for this
effect.
Oxidants, such as H2O2 target cysteine residues in Keap1 allow-
ing Nrf2 to escape Cul3-mediated degradation [2]. In agreement
with previous studies [23], we found that under basal conditions
Nrf2 was localized in the nuclei and that activation by H2O2
increased its stability, ARE-driven activity and anti-oxidant gene
expression.
Since HDAC and sirtuin activities have been shown to be
reduced in COPD [11,24], we measured the effects of HDAC and
sirtuin inhibition on Nrf2 protein and activity after stimulation
with H2O2. Both activity and stability of Nrf2, at baseline and with
H2O2 stimulation, were decreased after HDAC inhibition with TSA
treatment but there was no effect with sirtuin inhibition with sirt-
inol, thus conﬁrming that Class I and II HDACs are linked to Nrf2
stability. In fact, TSA was shown to reduce Nrf2 protein half-life
both under oxidative stress and at baseline. In primary MDMs,
TSA similarly impaired the H2O2 increase of Nrf2 protein levels
as we have seen in BEAS2B cells. The anti-oxidant response after
H2O2 stimulation, as measured by HO-1, was impaired in BEAS2B
cells and this was conﬁrmed in in vivo studies using mice. More-
over, in COPD, HDAC2 protein expression is known to be decreased
[11] and knock-down of HDAC2, but not HDAC1, resulted in de-
creased Nrf2 stability. This was further conﬁrmed in primary
MDMs, where HDAC2 and Nrf2 expressions correlated, whereas
no association was found with its inhibitor Keap1 and its positive
regulator DJ-1. In agreement with our results, a recent study dem-
onstrated that a mouse strain highly susceptible to emphysema,
showed higher basal level of ROS concurrent with lower levels of
Nrf2, HO-1 and HDAC2 compared to an emphysema insensitive-
strain [25]. This suggests that HDAC2 is at least one of the Class I
and II HDACs responsible for Nrf2 stability; however other HDACs
apart from HDAC1 could also be involved.
Recent work has shown that Nrf2 acetylation at various resi-
dues in its Neh1 DNA-binding domain are required for full Nrf2
trans-activation but not for its stability [13]. BEAS2B cells stimu-
lated with a proteasome inhibitor strongly stabilized and activated
Nrf2 probably due to the saturation of the proteasome [26]. Inter-
estingly, with proteasome inhibition, we found that Nrf2 was
highly acetylated, in agreement with Sun et al. [13]. However, inhi-
bition of HDAC activity by TSA showed that further acetylation of
other residues in Nrf2 might be critical for Nrf2 protein stability.
In the future, the residues contained in the Neh2 domain, the site
of redox-sensitive ubiquitin conjugation, responsible for Keap1
interaction [27], should be analyzed as well as both Neh3 and
Neh6 domains linked with protein stability [27,28]. Additionally,
we have shown that HDAC2 co-immunoprecipitated with Nrf2,
supporting the existence of a multi-molecular complex involving
Nrf2 and HDAC2.
Collectively, our results demonstrate that HDAC2 stabilizes Nrf2
protein expression. We show for the ﬁrst time that HDAC2 is asso-
ciated with Nrf2 and prevents its degradation probably by deacet-
ylation of lysine residues. As reduced HDAC2 activity is seen in
COPD as a result of oxidative stress, this could reduce activity of
Nrf2 so that an appropriate increase in antioxidant expression isblunted, thus increasing oxidative stress, which then further
reduces HDAC2 activity in a vicious circle. Restoring HDAC2
expression and activity in COPD cells could prevent Nrf2
down-regulation by increased Nrf2 deacetylation resulting in the
restoration of normal anti-oxidant defences.
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